Cargando…
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells
Deregulated oxidative metabolism is a hallmark of leukaemia. While tyrosine kinase inhibitors (TKIs) such as imatinib have increased survival of chronic myeloid leukaemia (CML) patients, they fail to eradicate disease-initiating leukemic stem cells (LSCs). Whether TKI-treated CML LSCs remain metabol...
Autores principales: | Rattigan, Kevin M., Brabcova, Zuzana, Sarnello, Daniele, Zarou, Martha M., Roy, Kiron, Kwan, Ryan, de Beauchamp, Lucie, Dawson, Amy, Ianniciello, Angela, Khalaf, Ahmed, Kalkman, Eric R., Scott, Mary T., Dunn, Karen, Sumpton, David, Michie, Alison M., Copland, Mhairi, Tardito, Saverio, Gottlieb, Eyal, Vignir Helgason, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435520/ https://www.ncbi.nlm.nih.gov/pubmed/37591854 http://dx.doi.org/10.1038/s41467-023-40222-z |
Ejemplares similares
-
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells
por: Rattigan, Kevin M, et al.
Publicado: (2023) -
Metabolism in stem cell–driven leukemia: parallels between hematopoiesis and immunity
por: Rattigan, Kevin M., et al.
Publicado: (2023) -
The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for Thought
por: Ianniciello, Angela, et al.
Publicado: (2018) -
Targeting mitochondrial oxidative phosphorylation eradicates
therapy-resistant chronic myeloid leukemic stem cells
por: Kuntz, Elodie M., et al.
Publicado: (2017) -
Folate metabolism: a re-emerging therapeutic target in haematological cancers
por: Zarou, Martha M., et al.
Publicado: (2021)